⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Exir Pharmaceutical Company and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Exir Pharmaceutical Company
↗Tehran, Iran
Exir Pharmaceutical Company is one of the largest and most advanced pharmaceutical manufacturers in Iran. Established in 1984 and operational since 1994, the company specializes in the production of a wide range of human pharmaceutical products, including tablets, capsules, ampoules, cartridges, syrups, and injectable vials.
The company operates state-of-the-art production lines and modern laboratory facilities, marketing over 160 types of pharmaceutical products. It is a publicly traded entity listed on the Tehran Stock Exchange (TSE) and is recognized for its significant contribution to the Iranian healthcare sector and its history of being an exemplary exporter.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:-
Industry:Pharmaceuticals
Sub-Industry:Generic & Specialty Pharmaceuticals
SIZE & FINANCIALS
Employees:501-1000
Founded:1984
Ownership:public
Status:operating
STOCK
Exchange:Tehran Stock Exchange
Ticker:EXIR1
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Injectables
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Exir Pharmaceutical Distribution Co.
Key Partnerships:Novo Nordisk (Historical cooperation), Nycomed (Historical cooperation)
COMPETITION
Position:Leader
LINKS
Website:exir.co.ir
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Exir Pharmaceutical Company. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.